| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10067-009-1097-Z |
| P698 | PubMed publication ID | 19184270 |
| P2093 | author name string | Kazuko Matsumoto | |
| Hitoaki Okazaki | |||
| Masahiro Iwamoto | |||
| Seiji Minota | |||
| Yuta Kawahara | |||
| Takao Nagashima | |||
| Masaki Yagi | |||
| Shino Takatori | |||
| P2860 | cites work | Adult-onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A | Q28167268 |
| Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease | Q34106179 | ||
| Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases | Q35555229 | ||
| Pathogenesis and management of adult-onset Still's disease | Q36583909 | ||
| Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. | Q36855193 | ||
| Rapid responses to anakinra in patients with refractory adult-onset Still's disease | Q40507008 | ||
| Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial | Q42410300 | ||
| Hemophagocytic syndrome and adult Still's disease associated with meningoencephalitis and unconsciousness | Q43786181 | ||
| Steroid-refractory severe hepatic failure in adult onset Still's disease responding to cyclosporine | Q46508865 | ||
| Cyclosporin A in the treatment of adult Still's disease | Q71750961 | ||
| Interleukin 6: a possible marker of disease activity in adult onset Still's disease | Q71935225 | ||
| Cyclosporin A in the treatment of adult onset Still's disease | Q73601139 | ||
| Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease | Q74267226 | ||
| Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease | Q78667433 | ||
| P433 | issue | 4 | |
| P921 | main subject | cyclosporine | Q367700 |
| tocilizumab | Q425154 | ||
| Still's disease | Q3281303 | ||
| P304 | page(s) | 485-487 | |
| P577 | publication date | 2009-01-30 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab | |
| P478 | volume | 28 |
| Q37782033 | A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature |
| Q42226048 | Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies |
| Q26852631 | Adult-onset Still's disease |
| Q51545663 | Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome |
| Q44131723 | Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease. |
| Q33388583 | Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab |
| Q33412732 | Life-threatening complications of adult-onset Still's disease |
| Q57143910 | Mechanisms, biomarkers and targets for adult-onset Still's disease |
| Q33751485 | Quotidian High Spiking Fevers in Adult Still's Disease. |
| Q36427179 | Successful Treatment with Intravenous Cyclophosphamide for Refractory Adult-Onset Still's Disease |
| Q37972994 | Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review |
| Q38058508 | Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases |
| Q35026728 | Three cases of previous smokers with rheumatoid arthritis who did not respond to tumor necrosis factor inhibitors were treated successfully with an anti-interleukin-6 receptor antibody |
| Q47978774 | Tocilizumab (Actemra). |
| Q40235629 | Tocilizumab for the treatment of adult-onset Still's disease: results from a case series. |
| Q35724900 | Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions |
| Q39445471 | Tocilizumab for uncontrollable systemic inflammatory response syndrome complicating adult-onset Still disease: Case report and review of literature |
| Q40350291 | Tocilizumab in refractory adult Still's disease |
| Q38056419 | Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence |
| Q37770789 | Tocilizumab: therapy and safety management |
| Q34043097 | Treatment of adult-onset Still's disease: a review |
| Q37829362 | Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature |
Search more.